DUGGAN ROBERT W (See Remarks) purchased 0.7% of their position (3.81M shares) of SUMMIT THERAPEUTICS INC. on the open market
Open‑market purchase worth $49.99M — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/12/2026ACC: 0001055919-26-000007
DirectorOfficer10% Owner· See Remarks
Since Sep 2020
+3.81M
Net shares
Net buyer
$49.99M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
3.81M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+3.81M
Price / share
$13.12
Trade value
$49.99M
% of position
0.7%
6/12/2026
570.07M→573.88M
Total
Net shares
+3.81M
Net value
$49.99M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/12/2026 | P · Purchase | +3.81M | $13.12 | $49.99M | 0.7% | 570.07M | 573.88M |
| Total | +3.81M | $49.99M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned25.82M
Common Stock
IndirectShares owned10.20M
Common Stock
IndirectShares owned76.68K
Common Stock
IndirectShares owned31K
Total
36.13M indirect36.13M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 25.82M | Indirect |
| Common Stock | 10.20M | Indirect |
| Common Stock | 76.68K | Indirect |
| Common Stock | 31K | Indirect |
| Total | 36.13M | 36.13M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported